Clinical Trials

Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome

Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound

Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce

Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound

Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce

Numinus Debuts 3rd Research Site In US, Touts Faster Services & More Participants

These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year

Numinus Debuts 3rd Research Site In US, Touts Faster Services & More Participants

These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year

Psychedelic Mushrooms Soon To Be Commercially Produced And Sold In Canada

Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing

Clinical Trials Recent News

FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder

After a full review of healthcare provider Ehave Inc.'s (OTC Pink: EHVVF) IND application, the U.S.

Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments

(Part four of a four-part series) See previous stories:

Reunion Neuroscience Presents Q2 2023 Financial Results & Pipeline Update

Psychedelics biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) reported its business update and fiscal results for the second quarter ended September 30, 2022.

MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials

Clinical-stage biotech company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) reported its financial results and updated on its programs pipeline of the third quarter ended September 30, 2022.

Atai Life Sciences' Q3 2022 Financials & Business Update, 'Strong Capability To Execute'

Clinical-stage psychedelics company atai Life Sciences N.V. (NASDAQ: ATAI) reported its financial results for the quarter ended September 30, 2022 and shared business developments.

Michigan Report: $20M In Cannabis Cash To Research PTSD Among Veterans And Using Weed Does Not Disqualify Unemployment Eligibility

The state of Michigan is funding two major medical cannabis research projects to the tune of $20 million with tax revenue from the state’s recreational marijuana program, announced Michigan’s Marijuana Regulatory Agency (MRA).

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

Why Novavax Shares Spiked 32% Today

Novavax, Inc (NASDAQ: NVAX) shares spiked nearly 32% in the after-hours and regular session on Thursday.

Why ChromaDex Shares Spiked 111% Today

Chromadex Corp (NASDAQ: CDXC) shares jumped 111% in the regular and after-hours sessions today. What Happened: The price movement on Thursday was accompanied by intense trading with volumes of 116.67 million. The average volume for ChromaDex shares is 523,511.

China's Sinopharm COVID-19 Vaccine Shows 79.34% Efficacy

China's Sinopharm Group (OTC: SHTDY) said Wednesday its COVID-19 vaccine candidate BBIBP-CorV — developed in partnership with Beijing Biological Products Institute Co.

AstraZeneca COVID-19 Vaccine Shows Up To 90% Efficacy In Advanced Trials

AstraZeneca Plc (NYSE: AZN) and Oxford University’s COVID-19 vaccine prevented 70% of the inoculated trial participants from developing COVID-19, early analysis of trial data indicates, Bloomberg

Johnson & Johnson Begins Two-Dose Phase 3 Trial Of COVID-19 Vaccine

Johnson & Johnson (NYSE: JNJ) has started the two-dose Phase 3 trial of its experimental COVID-19 vaccine, dubbed "ENSEMBLE 2," the pharmaceutical company an

Sinovac COVID-19 Vaccine Trial Halted In Brazil Over Adverse Event

Brazilian health regulator has decided to halt clinical trials of a frontrunning Chinese vaccine following a “severe adverse event” observed in a participant, Bloomberg reported Monday.

GW Pharmaceuticals Revenue Hits $137M, Tests Another Cannabis Plant-Based Drug

Biopharmaceutical company GW Pharmaceuticals plc (NASDAQ: GWPH) revealed Tuesday that its revenue for the third quarter hit $137.1 million, up by 51% year-over-year.

AstraZeneca Could Resume US COVID-19 Vaccine Trial This Week As FDA Review Complete: Report

Johnson & Johnson COVID-19 Vaccine Trial Paused Over Participant Developing Unexplained Illness

Johnson & Johnson’s (NYSE: JNJ) COVID-19 vaccine trial has been paused over a participant developing an unexplained illness, Stat reported late Monday.

Regeneron CEO Says More Testing Needed For Antibody Cocktail After Trump Touted It As COVID-19 'Cure'

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) CEO Leonard Schleifer in a televised interview suggested that more clinical testing was needed to measure the company's antibody cocktail's effecti

Novavax Shares Surge 7% As It Begins Late-Stage COVID-19 Vaccine Trials

Novavax, Inc (NASDAQ: NVAX) said Thursday it was launching a large-scale diverse Phase 3 study of its COVID-19 vaccine in the United Kingdom — causing a more than 7% spike in the company’s shares after the closing bell.

Sinovac Plans To Expand COVID-19 Vaccine Trials To Children And Adolescents

Sinovac Biotech has plans to expand the clinical trial of its COVID-19 vaccine trial to children and adolescents later this month.

AstraZeneca Gets India Go-Ahead To Resume COVID-19 Vaccine Trials, US Nod Awaited

AstraZeneca plc (NYSE: AZN) COVID-19 vaccine clinical trial is set to resume in India after local partner Serum Institute of India received the go-ahead from Indian regulators, Reuters reported Wednesday.

Pfizer Says COVID-19 Vaccine Only Showed Moderate Side-Effects In Preliminary Late-Stage Trials

Pfizer Inc (NYSE: PFE) on Tuesday said only mild-to-moderate side effects were observed in volunteers administered with its COVID-19 vaccine in late-stage human trials.

Pfizer Seeks FDA Nod To Expand Late-Stage COVID-19 Vaccine Trial

Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said Saturday they are seeking the United States Food and Drug Administration approval to expand the late-stage clinical trial of their COVID-19 vacc

AstraZeneca COVID-19 Vaccine Trial Halt A 'Wake-Up Call,' WHO Says

AstraZeneca Plc’s (NYSE: AZN) COVID-19 vaccine trial halt is an indicator that vaccine development is “not always a fast and a straight road,” according to the World Health Organization Chief Scientist Dr. Soumya Swaminathan.